Karin Jirström
271 – 280 of 342
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
PKC alpha expression is a marker for breast cancer aggressiveness
(
- Contribution to journal › Article
-
Mark
Increased androgen receptor expression in serous carcinoma of the ovary is associated with an improved survival
(
- Contribution to journal › Article
-
Mark
Up-regulation of cell cycle arrest protein BTG2 correlates with increased overall survival in breast cancer, as detected by immunohistochemistry using tissue microarray
(
- Contribution to journal › Article
-
Mark
STROMA-DERIVED MARKERS PREDICTING BREAST CANCER PROGNOSIS AND TREATMENT RESPONSE
(
- Contribution to journal › Published meeting abstract
-
Mark
Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer
(
- Contribution to journal › Article
-
Mark
Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer
(
- Contribution to journal › Article
-
Mark
p27(Kip1) is a predictive factor for tamoxifen treatment response but not a prognostic marker in premenopausal breast cancer patients.
(
- Contribution to journal › Article
-
Mark
Immunohistochemical detection of tyrosine phosphatase SHP-1 predicts outcome after radical prostatectomy for localized prostate cancer.
(
- Contribution to journal › Article
-
Mark
Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population-based lymph node negative breast cancer cohort.
(
- Contribution to journal › Article
-
Mark
Down-Regulation of the Oncogene Cyclin D1 Increases Migratory Capacity in Breast Cancer and Is Linked to Unfavorable Prognostic Features.
(
- Contribution to journal › Article